Compare Amphastar Pharmaceuticals Inc (AMPH) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

SPXL trades at $279.18, up 1.22% on the day, with a bullish technical signal from moving averages. The stock faces resistance near $281-$285 while supported at $271-$274. Recent news highlights AI-driven market optimism but notes Fed policy and earnings as key near-term catalysts. A dividend of $0.52 is scheduled for June 30, 2026.

Outlook remains positive given strong AI sector momentum, though stretched valuations and Fed tightening risks warrant caution. Earnings growth and sector rotation will dictate direction, with technical indicators suggesting potential consolidation before further upside.